These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9839931)

  • 41. Antigen- and receptor-driven regulatory mechanisms. X. The induction and suppression of hapten-specific granulomas.
    Ginsburg CH; McCluskey RT; Nepom JT; Takaoki M; Falchuk ZM; Benacerraf B; Greene MI
    Am J Pathol; 1982 Mar; 106(3):421-31. PubMed ID: 6175220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Possible synthesis of steroid-protein for immunization with a fixed narrow range of the hapten-protein ratio.
    Uscheva AA; Stankov BM; Zachariev SG; Marinova CP; Kanchev LN
    J Steroid Biochem; 1986 Mar; 24(3):699-702. PubMed ID: 3702446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of passively administered isologous anti-idiotypes directed against anti-carrier (ovalbumin) antibodies on the anti-hapten IgE and IgG antibody responses in BALB/c mice.
    Blaser K; Nakagawa T; De Weck AL
    Immunology; 1983 Mar; 48(3):423-31. PubMed ID: 6600704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of hapten density on immunogenicity for anti-ciprofloxacin antibody production in mice.
    Hu K; Huang X; Jiang Y; Qiu J; Fang W; Yang X
    Biosci Trends; 2012 Apr; 6(2):52-6. PubMed ID: 22621986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-performance capillary electrophoresis for characterization of hapten-protein conjugates used for production of antibodies against soyasaponin I.
    Frøkiaer H; Møller P; Sørensen H; Sørensen S
    J Chromatogr A; 1994 Oct; 680(2):437-45. PubMed ID: 7981825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of avidin-biotin technology for the characterization of a model hapten-protein conjugate.
    Dotsikas Y; Loukas YL
    J Immunoassay Immunochem; 2005; 26(4):285-93. PubMed ID: 16153013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of the anti-hapten IgE antibody response with hapten-modified spleen cells.
    Weber EA; Blaser K
    Eur J Immunol; 1986 Dec; 16(12):1527-31. PubMed ID: 2949982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hapten synthesis and antibody production for the development of a melamine immunoassay.
    Lei H; Shen Y; Song L; Yang J; Chevallier OP; Haughey SA; Wang H; Sun Y; Elliott CT
    Anal Chim Acta; 2010 Apr; 665(1):84-90. PubMed ID: 20381695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hapten-protein conjugates prepared by the mixed anhydride method. Cross-reactive antibodies in heterologous antisera.
    Gendloff EH; Casale WL; Ram BP; Tai JH; Pestka JJ; Hart LP
    J Immunol Methods; 1986 Aug; 92(1):15-20. PubMed ID: 3528298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation of antibodies specific to D-mannitol, a unique haptenic allergen, using reductively aminated D-mannose-bovine serum albumin conjugate as the immunogen.
    Hegde VL; Venkatesh YP
    Immunobiology; 2007; 212(2):119-28. PubMed ID: 17336832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biological Activity of the Carrier as a Factor in Immunogen Design for Haptens.
    Ertekin Ö; Akçael E; Kocaağa H; Öztürk S
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30441861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production of monoclonal antibodies to the N-methylcarbamate pesticide propoxur.
    Moreno MJ; Abad A; Montoya A
    J Agric Food Chem; 2001 Jan; 49(1):72-8. PubMed ID: 11170562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of the anti-idiotypic responses generated by antibodies to a protein and a hapten: a common interspecies idiotype on antibodies against human albumin induces an idiotypic network in rabbits.
    Comacchio RM; Bradley J; Hohmann AW
    Immunol Cell Biol; 1996 Feb; 74(1):72-80. PubMed ID: 8934657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mechanism of tolerance induction in thymus-derived lymphocytes; I. intracellular inactivation of hapten-reactive helper T lymphocytes by hapten-nonimmunogenic copolymer of D-amino acids.
    Hamaoka T; Yamaskita U; Takami T; Kitagawa M
    J Exp Med; 1975 Jun; 141(6):1308-28. PubMed ID: 47899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The suppressive effect of carrier priming on the response to a hapten-carrier conjugate.
    Elson CJ; Taylor RB
    Eur J Immunol; 1974 Oct; 4(10):682-7. PubMed ID: 4609768
    [No Abstract]   [Full Text] [Related]  

  • 56. A new enzyme-linked immunosorbent assay (ELISA) for spermidine using glutaraldehyde coupling of the hapten to carrier-coated microtiter plates.
    Fujiwara K; Kitagawa T
    J Biochem; 1993 Nov; 114(5):708-13. PubMed ID: 8113225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of hapten-carrier protein conjugates by nondenaturing gel electrophoresis.
    Kamps-Holtzapple C; Carlin RJ; Sheffield C; Kubena L; Stanker L; DeLoach JR
    J Immunol Methods; 1993 Sep; 164(2):245-53. PubMed ID: 8370930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation and characterization of diethoxy- and monoethoxy phosphylated ('aged') serine haptens and use in the production of monoclonal antibodies.
    Belabassi Y; Chao CK; Holly R; George KM; Nagy JO; Thompson CM
    Chem Biol Interact; 2014 Nov; 223():134-40. PubMed ID: 25261769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and characterization of immunogens for raising antibodies directed towards chelated alkali metals.
    Safi S; Asfari Z; Leroy M; Basset C; Quéméneur E; Vidaud C; Hagège A
    Analyst; 2009 Feb; 134(2):256-60. PubMed ID: 19173046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of reaginic antibody formation. III. Relationship between immunogenecity and tolerogenicity of hapten-carrier conjugates.
    Lee WY; Sehon AH
    J Immunol; 1976 Jun; 116(6):1711-8. PubMed ID: 58048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.